Rights to produce generic drugs in new EU member state under attack

It appears that the European Commission is also not very keen to allow the new members exemptions from regulations which grant pharmaceutical innovators so-called data exclusivity and limit generic drug producers' right to replicate recently invented new medicines. The Commission has suggested that all the new member states should apply together for a derogation in this regard, but since only Poland, Slovakia and Hungary have sought such a derogation, this could prove to be a difficult path, claims Cezary Śledziewski, president of the Polish Union of Pharmaceutical Industry Employers. (PZPPF). (Puls Biznesu, p. 8) T.J.